FDA approves Janssen’s HIV combination SymtuzaJanssen has won US approval for its once-daily HIV pill Symtuza (D/C/F/TAF), which it hopes will improve patient Share XFDA approves Janssen’s HIV combination Symtuzahttps://pharmaphorum.com/news/fda-janssen-hiv-symtuza/